Cargando…

Population Pharmacokinetics of Meropenem in Critically Ill Korean Patients and Effects of Extracorporeal Membrane Oxygenation

Limited studies have investigated population pharmacokinetic (PK) models and optimal dosage regimens of meropenem for critically ill adult patients using the probability of target attainment, including patients receiving extracorporeal membrane oxygenation (ECMO). A population PK analysis was conduc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Dong-Hwan, Kim, Hyoung-Soo, Park, Sunghoon, Kim, Hwan-il, Lee, Sun-Hee, Kim, Yong-Kyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625191/ https://www.ncbi.nlm.nih.gov/pubmed/34834278 http://dx.doi.org/10.3390/pharmaceutics13111861

Ejemplares similares

Population pharmacokinetics of piperacillin/tazobactam in critically ill Korean patients and the effects of extracorporeal membrane oxygenation
por: Kim, Yong Kyun, et al.
Publicado: (2022)

Pharmacokinetics and Monte Carlo Simulation of Meropenem in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation
por: Lee, Jae Ha, et al.
Publicado: (2021)

1540. A Population Pharmacokinetic Model for Vancomycin in Korean Patients Receiving Extracorporeal Membrane Oxygenation Therapy: A Prospective Study
por: Jung, Younghee, et al.
Publicado: (2019)

Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients Are Not Affected by Extracorporeal Membrane Oxygenation: A Matched Cohort Analysis
por: Gijsen, Matthias, et al.
Publicado: (2021)

Meropenem therapy in extracorporeal membrane oxygenation patients: an ongoing pharmacokinetic challenge
por: Honore, Patrick M., et al.
Publicado: (2015)

Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation Support
por: Zylbersztajn, Brenda, et al.
Publicado: (2021)

Population Pharmacokinetics and Monte Carlo Simulation of Cefepime in Critically Ill Patients with Hospital-Acquired/Ventilator-Associated Pneumonia
por: Seo, Hyeonji, et al.
Publicado: (2023)

Dose Optimization of Meropenem in Patients on Veno-Arterial Extracorporeal Membrane Oxygenation in Critically Ill Cardiac Patients: Pharmacokinetic/Pharmacodynamic Modeling
por: Kang, Soyoung, et al.
Publicado: (2022)

Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation
por: Yang, Seungwon, et al.
Publicado: (2017)

Blood Transfusion Strategies in Patients Undergoing Extracorporeal Membrane Oxygenation
por: Kim, Hyoung Soo, et al.
Publicado: (2017)

Different characteristics of bloodstream infection during venoarterial and venovenous extracorporeal membrane oxygenation in adult patients
por: Kim, Hyoung Soo, et al.
Publicado: (2021)

Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy
por: Hahn, Jongsung, et al.
Publicado: (2019)

Clinical outcomes of extracorporeal membrane oxygenation in acute traumatic lung injury: a retrospective study
por: Lee, Hong Kyu, et al.
Publicado: (2020)

Pharmacokinetics of meropenem in critically ill patients in Saudi Arabia
por: Alsultan, Abdullah, et al.
Publicado: (2021)

Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients
por: Gan, Yuhong, et al.
Publicado: (2023)

Pharmacokinetics Alterations in Critically Ill Pediatric Patients on Extracorporeal Membrane Oxygenation: A Systematic Review
por: Sutiman, Natalia, et al.
Publicado: (2020)

Use of Nafamostat Mesilate as an Anticoagulant during Extracorporeal Membrane Oxygenation
por: Han, Sang Jin, et al.
Publicado: (2011)

The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study
por: Shekar, Kiran, et al.
Publicado: (2014)

Extracorporeal membrane oxygenation in near-drowning patients with cardiac or pulmonary failure
por: Kim, Kun Il, et al.
Publicado: (2014)

Veno-Arterial-Venous Extracorporeal Membrane Oxygenation in a Critically Ill Patient with Coronavirus Disease 2019
por: Byun, Joung Hun, et al.
Publicado: (2020)

Association of pulmonary arterial pressure with volume status in patients with acute respiratory distress syndrome receiving extracorporeal membrane oxygenation
por: Hong, Tae Hwa, et al.
Publicado: (2022)

A systematic review on pharmacokinetic changes in critically ill patients: role of extracorporeal membrane oxygenation
por: Mousavi, S., et al.
Publicado: (2011)

1109. Pharmacokinetics and Exposure of Cefepime in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)
por: Kois, Abigail K, et al.
Publicado: (2021)

Transportation of Critically Ill Patients on Extracorporeal Membrane Oxygenation
por: Broman, L. Mikael, et al.
Publicado: (2016)

Outcomes of Urgent Interhospital Transportation for Extracorporeal Membrane Oxygenation Patients
por: Yang, Jun Tae, et al.
Publicado: (2022)

Population pharmacokinetics in critically ill neonates and infants undergoing extracorporeal membrane oxygenation: a literature review
por: Yalcin, Nadir, et al.
Publicado: (2022)

Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study)
por: Cheng, Vesa, et al.
Publicado: (2022)

Brain natriuretic peptide levels predict 6-month mortality in patients with cardiogenic shock who were weaned off extracorporeal membrane oxygenation
por: Kim, Hyoung Soo, et al.
Publicado: (2020)

Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation
por: Lyster, Haifa, et al.
Publicado: (2023)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
por: Goncalves-Pereira, João, et al.
Publicado: (2014)

Use of Venovenous Extracorporeal Membrane Oxygenation in Critically-Ill Patients With COVID-19
por: Jozwiak, Mathieu, et al.
Publicado: (2020)

Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy
por: Hahn, Jongsung, et al.
Publicado: (2021)

Nutrition Support in Critically Ill Cancer Patient Receiving Extracorporeal Membrane Oxygenation: A Case Report
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study
por: Ronda, Mar, et al.
Publicado: (2023)

The Influence of Extracorporeal Membrane Oxygenation on Antibiotic Pharmacokinetics
por: Peitz, Gregory J., et al.
Publicado: (2023)

Awakening in extracorporeal membrane oxygenation as a bridge to lung transplantation
por: Lee, Su Hwan
Publicado: (2022)

Evaluation of pharmacokinetic and pharmacodynamic parameters of meropenem in critically ill patients with acute kidney disease
por: Hassanpour, Rezvan, et al.
Publicado: (2021)

Carinal Reconstruction and Sleeve Right Upper Lobectomy Assisted with Extracorporeal Membrane Oxygenator for Non-small Cell Lung Cancer - A case report -
por: Lee, Hee Sung, et al.
Publicado: (2011)

Veno-arterial extracorporeal membrane oxygenation may be useful in critically ill COVID-19 patients with suspected cardiac injury
por: Heo, Eunyoung, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3pnr0kc2rg3nub32hlms8pttsi